Mandin, Ronniver C.
HRN: 24-46-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2024
CEFAZOLIN 1GM (VIAL)
01/22/2024
01/29/2024
IV
1g
Q8H
Lacerated Wound, L Knee
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes